"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(MEX-ih-leh-teen HIGH-droe-KLOR-ide)
Mexitil
Class: Antiarrhythmic

 Action Reduces rate of rise of action potential; decreases effective refractory period in Purkinje fibers; has local anesthetic actions.

 Indications Treatment of documented life-threatening ventricular arrhythmias such as sustained ventricular arrhythmias. Unlabeled use(s): Prevention of ventricular arrhythmias in acute phase of MI; reduction of pain, dysesthesia and paresthesia associated with diabetic neuropathy.

 Contraindications Preexisting second-or third-degree atrioventricular block (if pacemaker is not present); cardiogenic shock.

 Route/Dosage

Ventricular Arrhythmias

ADULTS: PO 200 mg q 8 hr initially, increasing up to 400 mg q 8 hr if necessary maximum 1200 mg/day). Adjust dose by 50–100 mg increments q 2–3 days. For rapid control of ventricular arrhythmias, give loading dose of 400 mg followed by 200 mg in 8 hr. With dose £ 300 mg q 8 hr, may give total daily dose q 12 hr (maximum 450 mg q 12 hr).

 Interactions

Aluminum-magnesium hydroxide, atropine, narcotics: May slow absorption. Cimetidine: May increase or decrease mexiletine plasma levels. Hydantoins, rifampin: May increase mexiletine clearance. Metoclorpramide: May accelerate absorption. Theophylline: May increase serum theophylline levels.

 Lab Test Interferences May result in abnormal liver function tests, positive ANA titer or thrombocytopenia.

 Adverse Reactions

CV: Palpitations; chest pain; increased ventricular arrhythmias or premature ventricular contractions; angina or angina-like pain; CHF. CNS: Dizziness; lightheadedness; tremor; nervousness; coordination difficulties; hanges in sleep habits; headache; paresthesias or numbness; weakness; fatigue; peech difficulties; confusion; depression. EENT: Blurred vision; tinnitus. GI: Nausea; constipation; abdominal pain; vomiting; diarrhea; anorexia; heartburn; ry mouth; changes in appetite. HEPA: Hepatitis; hepatic necrosis. RESP: Shortness of breath. OTHER: Fever; rash; nonspecific edema; arthralgias.

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established. Cardiovascular effects: Has proarrhythmic effect; therapy should be initiated in hospital. Convulsions: Have occurred; use drug with caution in patients with known seizure disorder. Hepatic impairment: Use drug with caution in patients with hepatic impairment. Reduce dosage in patients with severe liver disease. Urinary pH: Marked alterations in urinary pH may alter mexiletine elimination; avoid drugs or diets that alter pH.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer with food or antacids to reduce GI distress.
  • When transferring from lidocaine, stop lidocaine when first oral dose is administered.
  • Store at room temperature.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of blood dyscrasias and second- or third-degree heart block without pacemaker.
  • Maintain IV during conversion from lidocaine until suppression of arrhythmia appears satisfactory.
  • Perform continuous ECG monitoring. Evaluate when desired antiarrhythmic effect has been obtained.
  • Monitor BP continuously throughout therapy.
  • Monitor I&O.
  • Monitor drug serum levels to evaluate for toxic or subtherapeutic dosage regimens.
  • Monitor serum electrolytes and liver enzymes periodically throughout therapy.
  • If worsening of arrhythmia or CNS symptoms occurs, notify physician.
OVERDOSAGE: SIGNS & SYMPTOMS
  CNS symptoms, coma, respiratory arrest, dizziness, drowsiness, nausea, hypotension, sinus bradycardia, paresthesia, seizures

 Patient/Family Education

  • Instruct patient to take medication with food or antacid.
  • Teach patient to monitor pulse rate. Advise patient to notify physician if pulse rate is < 50 bpm or becomes irregular.
  • Explain that medication may cause dizziness and lightheadedness. Caution patient to take appropriate safety precautions.
  • Remind patient to carry identification describing cardiac disease and medication regimen.
  • Instruct patient to report these symptoms to physician: unexplained general tiredness, jaundice, fever, sore throat, bruising or bleeding.

Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below